IQVIA Holdings Inc. (IQV)
| Previous close | 227.04 |
| Open | 228.20 |
| Bid | 229.74 x 900 |
| Ask | 230.02 x 900 |
| Day's range | 226.95 - 230.28 |
| 52-week range | 167.42 - 261.73 |
| Volume | |
| Avg. volume | 949,818 |
| Market cap | 41.891B |
| Beta (5Y monthly) | 1.52 |
| PE ratio (TTM) | 31.45 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
IQVIA Reports First-Quarter 2024 Results
RESEARCH TRIANGLE PARK, N.C., May 02, 2024--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today reported financial results for the quarter ended March 31, 2024.
- Business Wire
IQVIA Celebrates Wendy Stewart and Susan Barnes, Winners of Healthcare Businesswoman's Association Luminary and Rising Star Awards
RESEARCH TRIANGLE PARK, N.C., April 23, 2024--IQVIA (NYSE:IQV) today announced that Wendy Stewart, president of Clinical Operations at IQVIA, and Susan Barnes, senior director of IQVIA Biotech Strategic Operations, have been honored with the Healthcare Businesswoman's Association Luminary and Rising Star Awards, respectively.
- Business Wire
IQVIA to Announce First-Quarter 2024 Results on May 2, 2024
RESEARCH TRIANGLE PARK, N.C., April 15, 2024--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV) will announce its first-quarter 2024 financial results before the market opens on Thursday, May 2, 2024. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at http://ir.iqvia.com.
